Menstrual symptoms
Conditions
Interventions
Take a commercially available vitamin D supplement (12.5microgram/day, 1 tablet/day) for 3 months. /Control group without supplementation
Sponsors
Doshisha women's of liberal arts
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Because analysis of serum before and after the intervention was required, the study targeted nursing students at University A who were undergoing antibody testing
Exclusion criteria
Exclusion criteria: Women with endometriosis, uterine fibroids, ovarian disease, or mental illness Women using OCP or LEP at the recruitment Women with complications such as bone disease, hyperkalemia, kidney disease, or congenital metabolic disease that affect vitamin D intake status Women with liver damage Women had side effects from taking vitamin D Women with bleeding tendencies Women with apple or gelatin allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstrual Distress Questionnaire ; MDQ | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale for pain during menstruation | — |
Countries
Japan
Contacts
Public ContactYukako Yoshioka
Kyoto prefectural university of medicine School of Nursing
Outcome results
None listed